INTRODUCTION AND OBJECTIVES: Cancer awareness campaigns aim to educate the general public about potentially treatable diseases in order to promote screening and early diagnosis. While the success of Breast Cancer Awareness Month has been documented, the efficacy of men's cancer awareness campaigns remains unknown. Using internet search volume as a surrogate for public interest, we sought to compare the efficacy of men's and women's cancer awareness campaigns.
METHODS: We utilized Google Trends to determine the relative search volumes (RSV) for "breast cancer," "prostate cancer," and "testicular cancer" from 2010 to 2017. Baseline annual RSV was calculated for each cancer by determining the median RSV for each year, excluding the 3-month period surrounding the cancer-specific awareness month. RSV for each cancer was then determined for the cancer-specific awareness month: breast cancer (October), prostate cancer (September), testicular cancer (April), and Movember (November). The primary outcome was a significant increase in cancer-specific RSV during the awareness month, defined as a twofold rise from baseline.
RESULTS: Baseline search volume was substantially higher for breast cancer. Breast Cancer Awareness Month led to a significant increase in cancer-specific RSV each year during the study period (mean increase 180.1%). In contrast, none of the men's cancer awareness campaigns led to a significant increase in cancer-specific RSV in any year during the study period. RSV for prostate cancer increased by 2.4% and 4.1% in September and November, respectively. RSV for testicular cancer increased by 9.3% and 6.2% in April and November, respectively. CONCLUSIONS: Despite similar incidence of breast and prostate cancer, men's cancer awareness campaigns did not increase cancer-specific RSV, whereas Breast Cancer Awareness Month consistently increased RSV. While additional metrics are needed to elucidate the efficacy of public health campaigns, the current data suggest the need for further examination of the root causes for differences in popular interest.
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